These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 29461668)
1. Time-lapse imaging points towards a non-toxic, mainly immune-driven mode of action of ingenol mebutate in the treatment of anogenital warts. Braun SA; Bünemann E; Baran J; Homey B; Gerber PA Exp Dermatol; 2018 Jun; 27(6):675-677. PubMed ID: 29461668 [TBL] [Abstract][Full Text] [Related]
2. Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital Warts. Braun SA; Bauer AT; Németh C; Rózsa A; Rusch L; Erpenbeck L; Schloer S; Silling S; Metze D; Gerber PA; Schneider SW; Gyulai R; Homey B Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362165 [TBL] [Abstract][Full Text] [Related]
3. Fast Ablation of Anogenital Warts of the Urinary Meatus by Low-dose Ingenol Mebutate Gel. Braun SA; Barsch M; Gerber PA Sex Transm Dis; 2018 Oct; 45(10):e80-e82. PubMed ID: 29794572 [TBL] [Abstract][Full Text] [Related]
4. An exploratory, prospective, open-label trial of ingenol mebutate gel 0.05% for the treatment of external anogenital warts. Larsen HK; Banzhaf CA; Thomsen SF; Gormsen M; Schopf RE; Haedersdal M J Eur Acad Dermatol Venereol; 2018 May; 32(5):825-831. PubMed ID: 29024025 [TBL] [Abstract][Full Text] [Related]
5. Ingenol mebutate induces a tumor cell-directed inflammatory response and antimicrobial peptides thereby promoting rapid tumor destruction and wound healing. Braun SA; Baran J; Schrumpf H; Buhren BA; Bölke E; Homey B; Gerber PA Eur J Med Res; 2018 Sep; 23(1):45. PubMed ID: 30266096 [TBL] [Abstract][Full Text] [Related]
6. Ingenol mebutate for the management of genital warts in sensitive anatomic locations. Braun SA; Gerber PA J Am Acad Dermatol; 2017 Jul; 77(1):e9-e10. PubMed ID: 28619577 [No Abstract] [Full Text] [Related]
7. Successful treatment of condylomata acuminata at the urethral meatus with high-dose ingenol mebutate gel: Report of two cases. Martinez-Domenech A; Magdaleno-Tapial J; Garcia-Legaz Martinez M; Hernández-Bel P Int J STD AIDS; 2019 Jul; 30(8):817-819. PubMed ID: 31046615 [No Abstract] [Full Text] [Related]
8. Ingenol Mebutate Gel 0.05% in the Treatment of Anogenital Warts: A Prospective Controlled Trial Comparing It With Topical Podophyllin Solution 25. Shahidi Dadras M; Bizaval Z; Hoormand M; Mozafari N Sex Transm Dis; 2020 May; 47(5):338-343. PubMed ID: 32149954 [TBL] [Abstract][Full Text] [Related]
9. Ingenol mebutate gel is effective against anogenital warts - a case series in 17 patients. Schopf RE J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):1041-3. PubMed ID: 25820019 [No Abstract] [Full Text] [Related]
10. Ingenol mebutate for the treatment of anogenital condylomata acuminata. Magdaleno-Tapial J; Valenzuela-Oñate C; Giacaman-von der Weth M; Ferrer-Guillén B; García-Legaz Martínez M; Martínez-Domenech Á; Hernández-Bel P Clin Exp Dermatol; 2019 Aug; 44(6):687-690. PubMed ID: 30460703 [No Abstract] [Full Text] [Related]
11. [Successful therapy of condylomata acuminata with ingenol mebutate]. Braun SA; Jansen TM; Homey B; Gerber PA Hautarzt; 2015 Apr; 66(4):223-5. PubMed ID: 25732966 [TBL] [Abstract][Full Text] [Related]
12. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization. Kostovic K; Gulin SJ; Mokos ZB; Ceovic R Anticancer Agents Med Chem; 2017; 17(10):1304-1311. PubMed ID: 28270072 [TBL] [Abstract][Full Text] [Related]
14. Analysis of apoptosis-associated molecules Erythroid differentiation regulator 1, bcl-2 and p53 in actinic keratosis after treatment with ingenol mebutate. Woo YR; Lim JH; Jeong SW; Cho DH; Park HJ Exp Dermatol; 2017 Nov; 26(11):1012-1017. PubMed ID: 28370377 [TBL] [Abstract][Full Text] [Related]
15. Effect of ingenol mebutate on actinic keratosis in a Korean population: A prospective clinical, dermoscopic and histopathological study from a single center. Kim JS; Woo YR; Kim M; Park HJ J Dermatol; 2018 Nov; 45(11):1324-1330. PubMed ID: 30260493 [TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742 [TBL] [Abstract][Full Text] [Related]
17. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study. Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of other sexually transmissible infections in patients with newly diagnosed anogenital warts in a sexual health clinic. Sturgiss EA; Jin F; Martin SJ; Grulich A; Bowden FJ Sex Health; 2010 Mar; 7(1):55-9. PubMed ID: 20152097 [TBL] [Abstract][Full Text] [Related]
19. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746 [TBL] [Abstract][Full Text] [Related]
20. Ranpirnase eradicates human papillomavirus in cultured cells and heals anogenital warts in a Phase I study. Squiquera L; Taxman DJ; Brendle SA; Torres R; Sulley J; Hodge T; Christensen N; Sidransky D Antivir Ther; 2017; 22(3):247-255. PubMed ID: 28121292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]